TitleAssociate Professor
InstitutionMD Anderson
Address1515 Holcombe Blvd
Houston TX 77030-4009
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Wang JY, Yu RQ, Huo L, Rao NJ, Lu WW, Zheng LW. Comparison of Vascular Morphometry in Jawbones and Long Bones: Micro-CT Study in a Rat Model Treated with Zoledronic Acid. Biomed Res Int. 2021; 2021:6651318. PMID: 34055992.
    2. Cao Y, Tang D, Xiang Y, Men L, Liu C, Zhou Q, Wu J, Huo L, Song T, Wang Y, Li Z, Wei R, Shen L, Yang Z, Hong J. Study on the Appropriate Timing of Postoperative Adaptive Radiotherapy for High-Grade Glioma. Cancer Manag Res. 2021; 13:3561-3572. PMID: 33953610.
    3. Yu RQ, Wang JY, Rao NJ, Huo L, Zheng LW. Effects of Bisphosphonates on Osseointegration of Dental Implants in Rabbit Model. Biomed Res Int. 2021; 2021:6689564. PMID: 33628807.
      Citations:    Fields:    Translation:HumansAnimals
    4. Yang L, Roy M, Lin H, Shen Y, Albarracin C, Huo L, Chen H, Wei B, Bedrosian I, Bu H, Wu Y. Validation of prognostic significance of the proposed uniform classification framework in neuroendocrine neoplasms of the breast. Breast Cancer Res Treat. 2021 Apr; 186(2):403-415. PMID: 33528758.
      Citations:    Fields:    
    5. Villodre ES, Gong Y, Hu X, Huo L, Yoon EC, Ueno NT, Woodward WA, Tripathy D, Song J, Debeb BG. NDRG1 Expression Is an Independent Prognostic Factor in Inflammatory Breast Cancer. Cancers (Basel). 2020 Dec 10; 12(12). PMID: 33321961.
    6. Huang X, Ding Q, Guo H, Gong Y, Zhao J, Zhao M, Sui D, Wu Y, Chen H, Liu H, Zhang J, Resetkova E, Moulder SL, Wang WL, Huo L. Comparison of three FDA-approved diagnostic immunohistochemistry assays of PD-L1 in triple-negative breast carcinoma. Hum Pathol. 2021 Feb; 108:42-50. PMID: 33221342.
      Citations:    Fields:    
    7. Chang G, Shi L, Ye Y, Shi H, Zeng L, Tiwary S, Huse JT, Huo L, Ma L, Ma Y, Zhang S, Zhu J, Xie V, Li P, Han L, He C, Huang S. YTHDF3 Induces the Translation of m6A-Enriched Gene Transcripts to Promote Breast Cancer Brain Metastasis. Cancer Cell. 2020 12 14; 38(6):857-871.e7. PMID: 33125861.
      Citations: 7     Fields:    Translation:HumansAnimalsCells
    8. Ai D, Yao J, Yang F, Huo L, Chen H, Lu W, Soto LMS, Jiang M, Raso MG, Wang S, Bell D, Liu J, Wang H, Tan D, Torres-Cabala C, Gan Q, Wu Y, Albarracin C, Hung MC, Meric-Bernstam F, Wistuba II, Prieto VG, Sahin AA, Ding Q. TRPS1: a highly sensitive and specific marker for breast carcinoma, especially for triple-negative breast cancer. Mod Pathol. 2021 04; 34(4):710-719. PMID: 33011748.
      Citations: 1     Fields:    
    9. Yam C, Rauch GM, Rahman T, Karuturi M, Ravenberg E, White J, Clayborn A, McCarthy P, Abouharb S, Lim B, Litton JK, Ramirez DL, Saleem S, Stec J, Symmans WF, Huo L, Damodaran S, Sun R, Moulder SL. A phase II study of Mirvetuximab Soravtansine in triple-negative breast cancer. Invest New Drugs. 2021 Apr; 39(2):509-515. PMID: 32984932.
      Citations: 1     Fields:    
    10. Yalniz C, Meis JM, Wang WL, Huo L, Candelaria RP, Adrada BE, Lane D, Santiago L, Huang ML. Proliferative fasciitis mimicking sarcoma in the breast. Breast J. 2020 10; 26(10):2072-2074. PMID: 32854140.
      Citations:    Fields:    
    11. Li Z, Zhang L, Liu Z, Huang T, Wang Y, Ma Y, Fang X, He Y, Zhou Y, Huo L, Wu J. miRNA-182 regulated MTSS1 inhibits proliferation and invasion in Glioma Cells. J Cancer. 2020; 11(19):5840-5851. PMID: 32913477.
    12. Guo H, Ding Q, Gong Y, Gilcrease MZ, Zhao M, Zhao J, Sui D, Wu Y, Chen H, Liu H, Zhang J, Resetkova E, Moulder SL, Wang WL, Huo L. Comparison of three scoring methods using the FDA-approved 22C3 immunohistochemistry assay to evaluate PD-L1 expression in breast cancer and their association with clinicopathologic factors. Breast Cancer Res. 2020 06 23; 22(1):69. PMID: 32576238.
      Citations: 1     Fields:    Translation:HumansCells
    13. Shannon VR, Subudhi SK, Huo L, Faiz SA. Diffuse alveolar hemorrhage with nivolumab monotherapy. Respir Med Case Rep. 2020; 30:101131. PMID: 32577370.
      Citations: 1     
    14. Zhang L, Yu X, Wei W, Pan X, Lu L, Xia J, Zheng W, Jia N, Huo L. Prediction of HCC microvascular invasion with gadobenate-enhanced MRI: correlation with pathology. Eur Radiol. 2020 Oct; 30(10):5327-5336. PMID: 32367417.
      Citations: 4     Fields:    Translation:Humans
    15. Wang JY, Huo L, Yu RQ, Rao NJ, Lu WW, Zheng LW. Skeletal Site-Specific Response of Jawbones and Long Bones to Surgical Interventions in Rats Treated with Zoledronic Acid. Biomed Res Int. 2019; 2019:5138175. PMID: 31930124.
      Citations:    Fields:    Translation:Animals
    16. Zhang XH, Huo L, Liu CF, Xu F, Lu XY, Huang B, Jia NY, Wu L, Shen F. Arterial hyperenhancement of small intrahepatic cholangiocarcinomas correlates with microvessel counts and patient survival. HPB (Oxford). 2020 08; 22(8):1197-1205. PMID: 31843444.
      Citations:    Fields:    
    17. Dai S, Yan Y, Xu Z, Zeng S, Qian L, Huo L, Li X, Sun L, Gong Z. Corrigendum: SCD1 Confers Temozolomide Resistance to Human Glioma Cells Via the Akt/GSK3ß/ß-Catenin Signaling Axis. Front Pharmacol. 2019; 10:1358. PMID: 31798454.
    18. Zhang L, Liu Z, Li J, Huang T, Wang Y, Chang L, Zheng W, Ma Y, Chen F, Gong X, Yuan Q, Teaw S, Fang X, Song T, Huo L, Li X, Xia X, Liu Z, Wu J. Genomic analysis of primary and recurrent gliomas reveals clinical outcome related molecular features. Sci Rep. 2019 11 05; 9(1):16058. PMID: 31690770.
      Citations: 11     Fields:    Translation:HumansCTClinical Trials
    19. Moseley TW, Shah SS, Brandt KR, Huo L. ASO Author Reflections: Mucocele-Like Lesions of the Breast-Excision or No Excision? Ann Surg Oncol. 2019 Dec; 26(Suppl 3):826-827. PMID: 31691107.
      Citations:    Fields:    Translation:Humans
    20. Yan Y, Xu Z, Chen X, Wang X, Zeng S, Zhao Z, Qian L, Li Z, Wei J, Huo L, Li X, Gong Z, Sun L. Novel Function of lncRNA ADAMTS9-AS2 in Promoting Temozolomide Resistance in Glioblastoma via Upregulating the FUS/MDM2 Ubiquitination Axis. Front Cell Dev Biol. 2019; 7:217. PMID: 31632968.
      Citations: 25     
    21. Chen X, Yan Y, Zhou J, Huo L, Qian L, Zeng S, Li Z, Wei J, Xu Z, Gong Z. Clinical prognostic value of isocitrate dehydrogenase mutation, O-6-methylguanine-DNA methyltransferase promoter methylation, and 1p19q co-deletion in glioma patients. Ann Transl Med. 2019 Oct; 7(20):541. PMID: 31807523.
      Citations: 12     
    22. Moseley TW, Shah SS, Nguyen CV, Rosenblat J, Resetkova E, Sneige N, Brandt KR, Huo L. Clinical Management of Mucocele-Like Lesions of the Breast with Limited or no Epithelial Atypia on Core Biopsy: Experience from Two Institutions. Ann Surg Oncol. 2019 Oct; 26(11):3478-3488. PMID: 31187364.
      Citations: 1     Fields:    Translation:Humans
    23. Bian Y, Meng L, Peng J, Li J, Wei R, Huo L, Yang H, Wang Y, Fu J, Shen L, Hong J. Effect of radiochemotherapy on the cognitive function and diffusion tensor and perfusion weighted imaging for high-grade gliomas: A prospective study. Sci Rep. 2019 04 12; 9(1):5967. PMID: 30979930.
      Citations: 1     Fields:    Translation:Humans
    24. Candelaria RP, Adrada BE, Wei W, Thompson AM, Santiago L, Lane DL, Huang ML, Arribas EM, Rauch GM, Symmans WF, Gilcrease MZ, Huo L, Lim B, Ueno NT, Moulder SL, Yang WT. Imaging features of triple-negative breast cancers according to androgen receptor status. Eur J Radiol. 2019 May; 114:167-174. PMID: 31005169.
      Citations: 1     Fields:    Translation:Humans
    25. Bai Y, Shi M, Yang X, Zhang W, Yang R, Wei X, Wei X, Duan L, Wang C, Mi R, Waqas Ahmed HA, Huo L, Chen Y, Xu F, Wu D, Sun K. The value of FDP/FIB and D-dimer/FIB ratios in predicting high-risk APL-related thrombosis. Leuk Res. 2019 04; 79:34-37. PMID: 30831481.
      Citations: 3     Fields:    Translation:Humans
    26. Ding Q, Wang Y, Zuo Z, Gong Y, Krishnamurthy S, Li CW, Lai YJ, Wei W, Wang J, Manyam GC, Diao L, Zhang X, Lin F, Symmans WF, Sun L, Liu CG, Liu X, Debeb BG, Ueno NT, Harano K, Alvarez RH, Wu Y, Cristofanilli M, Huo L. Decreased expression of microRNA-26b in locally advanced and inflammatory breast cancer. Hum Pathol. 2018 07; 77:121-129. PMID: 29689244.
      Citations: 7     Fields:    Translation:HumansCells
    27. Wang Y, Xie Y, Li X, Lin J, Zhang S, Li Z, Huo L, Gong R. MiR-876-5p acts as an inhibitor in hepatocellular carcinoma progression by targeting DNMT3A. Pathol Res Pract. 2018 Jul; 214(7):1024-1030. PMID: 29724530.
      Citations: 18     Fields:    Translation:HumansCells
    28. He J, Huo L, Ma J, Zhao J, Bassett RL, Sun X, Ueno NT, Lim B, Gong Y. Expression of Programmed Death Ligand 1 (PD-L1) in Posttreatment Primary Inflammatory Breast Cancers and Clinical Implications. Am J Clin Pathol. 2018 Feb 17; 149(3):253-261. PMID: 29425258.
      Citations: 5     Fields:    Translation:Humans
    29. Dai S, Yan Y, Xu Z, Zeng S, Qian L, Huo L, Li X, Sun L, Gong Z. SCD1 Confers Temozolomide Resistance to Human Glioma Cells via the Akt/GSK3ß/ß-Catenin Signaling Axis. Front Pharmacol. 2017; 8:960. PMID: 29354058.
      Citations: 21     
    30. Fujii T, Reuben JM, Huo L, Espinosa Fernandez JR, Gong Y, Krupa R, Suraneni MV, Graf RP, Lee J, Greene S, Rodriguez A, Dugan L, Louw J, Lim B, Barcenas CH, Marx AN, Tripathy D, Wang Y, Landers M, Dittamore R, Ueno NT. Androgen receptor expression on circulating tumor cells in metastatic breast cancer. PLoS One. 2017; 12(9):e0185231. PMID: 28957377.
      Citations: 8     Fields:    Translation:HumansCells
    31. Su G, Liu Z, Huo L, Li C, Zhang M. [Neuronavigator-assisted microsurgical resection of glioma located in cerebral functional areas]. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2017 May 28; 42(5):542-545. PMID: 28626100.
      Citations:    Fields:    Translation:Humans
    32. Wu H, Bi J, Peng Y, Huo L, Yu X, Yang Z, Zhou Y, Qin L, Xu Y, Liao L, Xie Y, Conneely OM, Jonkers J, Xu J. Nuclear receptor NR4A1 is a tumor suppressor down-regulated in triple-negative breast cancer. Oncotarget. 2017 Aug 15; 8(33):54364-54377. PMID: 28903348.
      Citations: 15     Fields:    
    33. Li X, Yang J, Krishnamurti U, Huo L, Ward KC, O'Regan R, Peng L. Hormone Receptor-Positive Breast Cancer Has a Worse Prognosis in Male Than in Female Patients. Clin Breast Cancer. 2017 08; 17(5):356-366. PMID: 28576631.
      Citations: 7     Fields:    Translation:Humans
    34. Chen H, Singh RR, Lu X, Huo L, Yao H, Aldape K, Abraham R, Virani S, Mehrotra M, Mishra BM, Bousamra A, Albarracin C, Wu Y, Roy-Chowdhuri S, Kanagal-Shamanna R, Routbort MJ, Medeiros LJ, Patel KP, Broaddus R, Sahin A, Luthra R. Genome-wide copy number aberrations and HER2 and FGFR1 alterations in primary breast cancer by molecular inversion probe microarray. Oncotarget. 2017 02 14; 8(7):10845-10857. PMID: 28125801.
      Citations: 5     Fields:    Translation:HumansCells
    35. Li X, Yang J, Peng L, Sahin AA, Huo L, Ward KC, O'Regan R, Torres MA, Meisel JL. Triple-negative breast cancer has worse overall survival and cause-specific survival than non-triple-negative breast cancer. Breast Cancer Res Treat. 2017 01; 161(2):279-287. PMID: 27888421.
      Citations: 61     Fields:    Translation:Humans
    36. Kono M, Fujii T, Lyons GR, Huo L, Bassett R, Gong Y, Karuturi MS, Tripathy D, Ueno NT. Impact of androgen receptor expression in fluoxymesterone-treated estrogen receptor-positive metastatic breast cancer refractory to contemporary hormonal therapy. Breast Cancer Res Treat. 2016 11; 160(1):101-109. PMID: 27663436.
      Citations: 3     Fields:    Translation:Humans
    37. He H, Plaxco JS, Wei W, Huo L, Candelaria RP, Kuerer HM, Yang WT. Incremental cancer detection using breast ultrasonography versus breast magnetic resonance imaging in the evaluation of newly diagnosed breast cancer patients. Br J Radiol. 2016 Sep; 89(1065):20160401. PMID: 27384241.
      Citations:    Fields:    Translation:Humans
    38. Yang Z, Zhang Z, Wang X, Hu Y, Lyu Z, Huo L, Wei R, Fu J, Hong J. Intensity-modulated radiotherapy for gliomas:dosimetric effects of changes in gross tumor volume on organs at risk and healthy brain tissue. Onco Targets Ther. 2016; 9:3545-54. PMID: 27366091.
      Citations: 9     
    39. Vila J, Mittendorf EA, Farante G, Bassett RL, Veronesi P, Galimberti V, Peradze N, Stauder MC, Chavez-MacGregor M, Litton JF, Huo L, Kuerer HM, Hunt KK, Caudle AS. Nomograms for Predicting Axillary Response to Neoadjuvant Chemotherapy in Clinically Node-Positive Patients with Breast Cancer. Ann Surg Oncol. 2016 10; 23(11):3501-3509. PMID: 27216742.
      Citations: 12     Fields:    Translation:Humans
    40. Guo Y, Huo L, Wang P, Huang L, Chai C, Sun F, Xia S, Shen W. Evaluating the Microcirculation of Normal Extraocular Muscles Using Quantitative Dynamic Contrast-Enhanced Magnetic Resonance Imaging. J Comput Assist Tomogr. 2016 May-Jun; 40(3):419-23. PMID: 26953768.
      Citations: 1     Fields:    Translation:Humans
    41. Yuan J, Lei M, Yang Z, Fu J, Huo L, Hong J. Dosimetric comparison between intensity-modulated radiotherapy and RapidArc with single arc and dual arc for malignant glioma involving the parietal lobe. Mol Clin Oncol. 2016 Jul; 5(1):181-188. PMID: 27330795.
    42. Debeb BG, Lacerda L, Anfossi S, Diagaradjane P, Chu K, Bambhroliya A, Huo L, Wei C, Larson RA, Wolfe AR, Xu W, Smith DL, Li L, Ivan C, Allen PK, Wu W, Calin GA, Krishnamurthy S, Zhang XH, Buchholz TA, Ueno NT, Reuben JM, Woodward WA. miR-141-Mediated Regulation of Brain Metastasis From Breast Cancer. J Natl Cancer Inst. 2016 08; 108(8). PMID: 27075851.
      Citations: 30     Fields:    Translation:HumansAnimalsCells
    43. Liu XL, Rao NJ, Huo L, Hu X, Lu WW, Zheng LW. The influence of locally applied granulocyte-colony stimulating factor on osteoporotic bone. Clin Oral Implants Res. 2017 May; 28(5):586-593. PMID: 27038192.
      Citations: 1     Fields:    Translation:Animals
    44. Huo L, Wang Y, Gong Y, Krishnamurthy S, Wang J, Diao L, Liu CG, Liu X, Lin F, Symmans WF, Wei W, Zhang X, Sun L, Alvarez RH, Ueno NT, Fouad TM, Harano K, Debeb BG, Wu Y, Reuben J, Cristofanilli M, Zuo Z. MicroRNA expression profiling identifies decreased expression of miR-205 in inflammatory breast cancer. Mod Pathol. 2016 Apr; 29(4):330-46. PMID: 26916073.
      Citations: 15     Fields:    Translation:Humans
    45. Wolfe AR, Bambhroliya A, Reddy JP, Debeb BG, Huo L, Larson R, Li L, Ueno NT, Woodward WA. MiR-33a Decreases High-Density Lipoprotein-Induced Radiation Sensitivity in Breast Cancer. Int J Radiat Oncol Biol Phys. 2016 06 01; 95(2):791-9. PMID: 27055396.
      Citations: 9     Fields:    Translation:HumansCells
    46. Liao Q, Liu W, Liu Y, Wang F, Wang C, Zhang J, Chu M, Jiang D, Xiao L, Shao W, Sheng Z, Tao X, Huo L, Yin CC, Zhang Y, Lee G, Huang J, Li Z, Qiu X. Aberrant high expression of immunoglobulin G in epithelial stem/progenitor-like cells contributes to tumor initiation and metastasis. Oncotarget. 2015 Nov 24; 6(37):40081-94. PMID: 26472025.
      Citations: 13     Fields:    Translation:HumansAnimalsCells
    47. Li CL, Seneviratne CJ, Huo L, Lu WW, Zheng LW. Impact of Actinomyces naeslundii on bisphosphonate-related osteonecrosis of the jaws in ovariectomized rats with periodontitis. J Craniomaxillofac Surg. 2015 Oct; 43(8):1662-9. PMID: 26293192.
      Citations: 1     Fields:    Translation:AnimalsCells
    48. Liu H, Liu Z, Jiang B, Huo L, Liu J, Lu J. Synthetic miR-145 Mimic Enhances the Cytotoxic Effect of the Antiangiogenic Drug Sunitinib in Glioblastoma. Cell Biochem Biophys. 2015 Jun; 72(2):551-7. PMID: 25564360.
      Citations: 7     Fields:    Translation:HumansCells
    49. Huo L, Gong Y, Guo M, Gilcrease MZ, Wu Y, Zhang H, Zhang J, Resetkova E, Hunt KK, Deavers MT. GATA-binding protein 3 enhances the utility of gross cystic disease fluid protein-15 and mammaglobin A in triple-negative breast cancer by immunohistochemistry. Histopathology. 2015 Aug; 67(2):245-54. PMID: 25564996.
      Citations: 5     Fields:    Translation:Humans
    50. Liu H, Liu Z, Jiang B, Ding X, Huo L, Wan X, Liu J, Xia Z. Prognostic Significance of Hyperglycemia in Patients with Brain Tumors: a Meta-Analysis. Mol Neurobiol. 2016 Apr; 53(3):1654-1660. PMID: 25687433.
      Citations: 1     Fields:    Translation:Humans
    51. Thaker NG, Hoffman KE, Stauder MC, Shaitelman SF, Strom EA, Tereffe W, Smith BD, Perkins GH, Huo L, Munsell MF, Pusztai L, Buchholz TA, Woodward WA. The 21-gene recurrence score complements IBTR! Estimates in early-stage, hormone receptor-positive, HER2-normal, lymph node-negative breast cancer. Springerplus. 2015; 4:36. PMID: 25674496.
      Citations: 3     
    52. Tang G, Wu J, Xiao G, Huo L. MiR-203 sensitizes glioma cells to temozolomide and inhibits glioma cell invasion by targeting E2F3. Mol Med Rep. 2015 Apr; 11(4):2838-44. PMID: 25515700.
      Citations: 6     Fields:    Translation:HumansCells
    53. Chen J, Lee HJ, Wu X, Huo L, Kim SJ, Xu L, Wang Y, He J, Bollu LR, Gao G, Su F, Briggs J, Liu X, Melman T, Asara JM, Fidler IJ, Cantley LC, Locasale JW, Weihua Z. Gain of glucose-independent growth upon metastasis of breast cancer cells to the brain. Cancer Res. 2015 Feb 01; 75(3):554-65. PMID: 25511375.
      Citations: 48     Fields:    Translation:HumansAnimalsCells
    54. Zhang S, Huo L, Arribas E, Middleton LP. Adenomyoepithelioma of the breast with associated atypical lobular hyperplasia: a previously unrecognized association with management implications. Ann Diagn Pathol. 2015 Feb; 19(1):20-3. PMID: 25631879.
      Citations:    Fields:    Translation:Humans
    55. Huo L, Wang X, Allen PK, Wang L, Liao Y, Han Z, Shen L, Tu Q, Zhong M, Zhuang Y, Li J, Hong J. Predictors of long-term survival following postoperative radiochemotherapy for pathologically confirmed suprasellar germ cell tumors. Mol Clin Oncol. 2015 Mar; 3(2):430-434. PMID: 25798281.
      Citations: 1     
    56. Guo M, Khanna A, Feng J, Patel S, Zhang W, Gong Y, Huo L, Staerkel G. Analytical performance of cervista HPV 16/18 in SurePath pap specimens. Diagn Cytopathol. 2015 Apr; 43(4):301-6. PMID: 25352375.
      Citations:    Fields:    Translation:HumansCells
    57. Adrada BE, Huo L, Lane DL, Arribas EM, Resetkova E, Yang W. Histopathologic correlation of residual mammographic microcalcifications after neoadjuvant chemotherapy for locally advanced breast cancer. Ann Surg Oncol. 2015 Apr; 22(4):1111-7. PMID: 25287438.
      Citations: 11     Fields:    Translation:Humans
    58. Qi J, Huo L, Zhu YT, Zhu YJ. Absent, small or homeotic 2-like protein (ASH2L) enhances the transcription of the estrogen receptor a gene through GATA-binding protein 3 (GATA3). J Biol Chem. 2014 Nov 07; 289(45):31373-81. PMID: 25258321.
      Citations: 7     Fields:    Translation:HumansAnimalsCells
    59. Rueth NM, Black DM, Limmer AR, Gabriel E, Huo L, Fornage BD, Dogan BE, Chavez-MacGregor M, Yi M, Hunt KK, Strom EA. Breast conservation in the setting of contemporary multimodality treatment provides excellent outcomes for patients with occult primary breast cancer. Ann Surg Oncol. 2015 Jan; 22(1):90-5. PMID: 25249256.
      Citations: 12     Fields:    Translation:HumansCTClinical Trials
    60. Wang H, Ji R, Meng J, Cui Q, Zou W, Li L, Wang G, Sun L, Li Z, Huo L, Fan Y, Penny DJ. Functional changes in pulmonary arterial endothelial cells associated with BMPR2 mutations. PLoS One. 2014; 9(9):e106703. PMID: 25187962.
      Citations: 5     Fields:    Translation:HumansCells
    61. Debeb BG, Gong Y, Atkinson RL, Sneige N, Huo L, Gonzalez-Angulo AM, Hung MC, Valero V, Ueno NT, Woodward WA. EZH2 expression correlates with locoregional recurrence after radiation in inflammatory breast cancer. J Exp Clin Cancer Res. 2014 Jul 23; 33:58. PMID: 25051981.
      Citations: 10     Fields:    Translation:Humans
    62. Xiang DB, Wei B, Abraham SC, Huo L, Albarracin CT, Zhang H, Babiera G, Caudle AS, Akay CL, Rao P, Zhao YJ, Lu X, Wu Y. Molecular cytogenetic characterization of mammary neuroendocrine carcinoma. Hum Pathol. 2014 Sep; 45(9):1951-6. PMID: 25074542.
      Citations: 3     Fields:    Translation:HumansCells
    63. Gong Y, Wei W, Wu Y, Ueno NT, Huo L. Expression of androgen receptor in inflammatory breast cancer and its clinical relevance. Cancer. 2014 Jun 15; 120(12):1775-9. PMID: 24634055.
      Citations: 2     Fields:    Translation:Humans
    64. Yi M, Huo L, Koenig KB, Mittendorf EA, Meric-Bernstam F, Kuerer HM, Bedrosian I, Buzdar AU, Symmans WF, Crow JR, Bender M, Shah RR, Hortobagyi GN, Hunt KK. Which threshold for ER positivity? a retrospective study based on 9639 patients. Ann Oncol. 2014 May; 25(5):1004-11. PMID: 24562447.
      Citations: 33     Fields:    Translation:Humans
    65. Akay CL, Ueno NT, Chisholm GB, Hortobagyi GN, Woodward WA, Alvarez RH, Bedrosian I, Kuerer HM, Hunt KK, Huo L, Babiera GV. Primary tumor resection as a component of multimodality treatment may improve local control and survival in patients with stage IV inflammatory breast cancer. Cancer. 2014 May 01; 120(9):1319-28. PMID: 24510381.
      Citations: 9     Fields:    Translation:Humans
    66. Gong Y, Wang J, Huo L, Wei W, Ueno NT, Woodward WA. Aldehyde dehydrogenase 1 expression in inflammatory breast cancer as measured by immunohistochemical staining. Clin Breast Cancer. 2014 Jun; 14(3):e81-8. PMID: 24461456.
      Citations: 5     Fields:    Translation:HumansCells
    67. Nayak A, Carkaci S, Gilcrease MZ, Liu P, Middleton LP, Bassett RL, Zhang J, Zhang H, Coyne RL, Bevers TB, Sneige N, Huo L. Benign papillomas without atypia diagnosed on core needle biopsy: experience from a single institution and proposed criteria for excision. Clin Breast Cancer. 2013 Dec; 13(6):439-49. PMID: 24119786.
      Citations: 7     Fields:    Translation:HumansCTClinical Trials
    68. Krishnamurthy S, Woodward W, Yang W, Reuben JM, Tepperberg J, Ogura D, Niwa S, Huo L, Gong Y, El-Zein R, Gonzalez-Angulo AM, Chavez-Macgregor M, Alvarez R, Lucci A, Valero V, Ueno NT. Status of the anaplastic lymphoma kinase (ALK) gene in inflammatory breast carcinoma. Springerplus. 2013; 2:409. PMID: 24156086.
      Citations: 7     
    69. Hong J, Wang X, Peng Y, Wang L, Huo L, Han Z, Tu Q. [Clinical analysis of 45 patients with intracranial germinoma treated by radiotherapy]. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2013 Mar; 38(3):262-7. PMID: 23545822.
      Citations:    Fields:    Translation:Humans
    70. Huo L, Zhang J, Gilcrease MZ, Gong Y, Wu Y, Zhang H, Resetkova E, Hunt KK, Deavers MT. Gross cystic disease fluid protein-15 and mammaglobin A expression determined by immunohistochemistry is of limited utility in triple-negative breast cancer. Histopathology. 2013 Jan; 62(2):267-74. PMID: 22963676.
      Citations: 8     Fields:    Translation:Humans
    71. Li X, Deavers MT, Guo M, Liu P, Gong Y, Albarracin CT, Middleton LP, Huo L. The effect of prolonged cold ischemia time on estrogen receptor immunohistochemistry in breast cancer. Mod Pathol. 2013 Jan; 26(1):71-8. PMID: 22899286.
      Citations: 4     Fields:    Translation:Humans
    72. Xiao Y, Lu L, Zhang A, Zhang Y, Sun L, Huo L, Li F. Highly enhanced acetone sensing performances of porous and single crystalline ZnO nanosheets: high percentage of exposed (100) facets working together with surface modification with Pd nanoparticles. ACS Appl Mater Interfaces. 2012 Aug; 4(8):3797-804. PMID: 22853192.
      Citations: 7     Fields:    Translation:Cells
    73. Zhao L, Gong Y, Wang J, Dawlett M, Huo L, Caraway NP, Guo M. Ultrasound-guided fine-needle aspiration biopsy of thyroid bed lesions from patients with thyroidectomy for thyroid carcinomas. Cancer Cytopathol. 2013 Feb; 121(2):101-7. PMID: 22605565.
      Citations: 3     Fields:    Translation:Humans
    74. Xu J, Wan M, He Q, Bassett RL, Fu X, Chen AC, Shi F, Creighton CJ, Schiff R, Huo L, Liu D. SGK3 is associated with estrogen receptor expression in breast cancer. Breast Cancer Res Treat. 2012 Jul; 134(2):531-41. PMID: 22576469.
      Citations: 13     Fields:    Translation:HumansCells
    75. Wang Z, Meng CJ, Shen XM, Shu Z, Ma C, Zhu GQ, Liu HX, He WC, Sun XB, Huo L, Zhang J, Chen G. Potential contribution of hypoxia-inducible factor-1a, aquaporin-4, and matrix metalloproteinase-9 to blood-brain barrier disruption and brain edema after experimental subarachnoid hemorrhage. J Mol Neurosci. 2012 Sep; 48(1):273-80. PMID: 22528459.
      Citations: 34     Fields:    Translation:Animals
    76. Adejolu M, Huo L, Rohren E, Santiago L, Yang WT. False-positive lesions mimicking breast cancer on FDG PET and PET/CT. AJR Am J Roentgenol. 2012 Mar; 198(3):W304-14. PMID: 22358030.
      Citations: 28     Fields:    Translation:Humans
    77. Wang Z, Ma C, Meng CJ, Zhu GQ, Sun XB, Huo L, Zhang J, Liu HX, He WC, Shen XM, Shu Z, Chen G. Melatonin activates the Nrf2-ARE pathway when it protects against early brain injury in a subarachnoid hemorrhage model. J Pineal Res. 2012 Sep; 53(2):129-37. PMID: 22304528.
      Citations: 54     Fields:    Translation:AnimalsCells
    78. Huo L. A practical approach to grossing breast specimens. Ann Diagn Pathol. 2011 Aug; 15(4):291-301. PMID: 21745648.
      Citations: 4     Fields:    Translation:Humans
    79. McLemore MS, Huo L, Deavers MT, Curry JL, Torres-Cabala CA, Wang WL, Prieto VG. Cutaneous epithelioid angiomatous nodule of the chest wall with expression of estrogen receptor: a mimic of carcinoma and a potential diagnostic pitfall. J Cutan Pathol. 2011 Oct; 38(10):818-22. PMID: 21752053.
      Citations: 3     Fields:    Translation:Humans
    80. Gong Y, Huo L, Liu P, Sneige N, Sun X, Ueno NT, Lucci A, Buchholz TA, Valero V, Cristofanilli M. Polycomb group protein EZH2 is frequently expressed in inflammatory breast cancer and is predictive of worse clinical outcome. Cancer. 2011 Dec 15; 117(24):5476-84. PMID: 21713757.
      Citations: 32     Fields:    Translation:Humans
    81. Tang F, Wei B, Tian Z, Gilcrease MZ, Huo L, Albarracin CT, Resetkova E, Zhang H, Sahin A, Chen J, Bu H, Abraham S, Wu Y. Invasive mammary carcinoma with neuroendocrine differentiation: histological features and diagnostic challenges. Histopathology. 2011 Jul; 59(1):106-15. PMID: 21668471.
      Citations: 7     Fields:    Translation:Humans
    82. Lee YS, Mathew J, Dogan BE, Resetkova E, Huo L, Yang WT. Imaging features of micropapillary DCIS: correlation with clinical and histopathological findings. Acad Radiol. 2011 Jul; 18(7):797-803. PMID: 21419669.
      Citations: 1     Fields:    Translation:Humans
    83. Tian Z, Wei B, Tang F, Wei W, Gilcrease MZ, Huo L, Albarracin CT, Resetkova E, Middleton L, Sahin A, Xing Y, Hunt KK, Chen J, Bu H, Rashid A, Abraham SC, Wu Y. Prognostic significance of tumor grading and staging in mammary carcinomas with neuroendocrine differentiation. Hum Pathol. 2011 Aug; 42(8):1169-77. PMID: 21334720.
      Citations: 16     Fields:    Translation:HumansCells
    84. Lester TR, Hunt KK, Nayeemuddin KM, Bassett RL, Gonzalez-Angulo AM, Feig BW, Huo L, Rourke LL, Davis WG, Valero V, Gilcrease MZ. Metaplastic sarcomatoid carcinoma of the breast appears more aggressive than other triple receptor-negative breast cancers. Breast Cancer Res Treat. 2012 Jan; 131(1):41-8. PMID: 21331622.
      Citations: 17     Fields:    Translation:Humans
    85. Chen R, Yang L, Fang J, Huo L, Zhang M, Chen F, Liu J, Wu J, Wang Y. RRP22: a novel neural tumor suppressor for astrocytoma. Med Oncol. 2012 Mar; 29(1):332-9. PMID: 21264544.
      Citations:    Fields:    Translation:Humans
    86. Huo L, Bell D, Qiu H, Sahin A, Wu Y, Sneige N. Paneth cell-like eosinophilic cytoplasmic granules in breast carcinoma. Ann Diagn Pathol. 2011 Apr; 15(2):84-92. PMID: 21163678.
      Citations: 6     Fields:    Translation:HumansCells
    87. Brown AS, Hunt KK, Shen J, Huo L, Babiera GV, Ross MI, Meric-Bernstam F, Feig BW, Kuerer HM, Boughey JC, Ching CD, Gilcrease MZ. Histologic changes associated with false-negative sentinel lymph nodes after preoperative chemotherapy in patients with confirmed lymph node-positive breast cancer before treatment. Cancer. 2010 Jun 15; 116(12):2878-83. PMID: 20564394.
      Citations: 9     Fields:    Translation:Humans
    88. Albarracin C, Edgerton ME, Gilcrease MZ, Huo L, Krishnamurthy S, Middleton LP, Resetkova E, Sahin AA, Sneige N, Fraser WS, Wu Y. Is it too soon to start reporting HER2 genetic heterogeneity? Arch Pathol Lab Med. 2010 Feb; 134(2):162-3; author reply 163. PMID: 20121597.
      Citations:    Fields:    Translation:Humans
    89. Huo L, Bi C, Fang J, Wang Y, Zhang M, Chen F. [Microsurgical treatment and prevention of postoperative complications for the fourth ventricle tumors in adults]. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2009 Jul; 34(7):642-5. PMID: 19648678.
      Citations: 1     Fields:    Translation:Humans
    90. Huo L, Gilcrease MZ. Fibroepithelial lesions of the breast with pleomorphic stromal giant cells: a clinicopathologic study of 4 cases and review of the literature. Ann Diagn Pathol. 2009 Aug; 13(4):226-32. PMID: 19608080.
      Citations: 1     Fields:    Translation:HumansCells
    91. Zhang M, Huo L, Wang J, Ma Z, Fang J, Rao Y, Tan Z, Zhang Z. [Microsurgery techniques for insular glioma]. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2009 Apr; 34(4):345-8. PMID: 19411754.
      Citations: 1     Fields:    Translation:Humans
    92. Nguyen CV, Deavers MT, Quinones J, Huo L. Estrogen receptor immunohistochemistry for confirmation of sentinel lymph node metastasis in cases with equivocal cytokeratin positivity. Appl Immunohistochem Mol Morphol. 2009 Mar; 17(2):139-45. PMID: 19521277.
      Citations:    Fields:    Translation:Humans
    93. Song T, Wu J, Fang F, Chen F, Huo L, Zhang M, Wu L, Zhai Z, Yang L, Fang J. Correlation analysis between the expression of P21WAF1/CIP1, P16 proteins and human glioma. Clin Exp Med. 2008 Sep; 8(3):151-7. PMID: 18791688.
      Citations: 1     Fields:    Translation:HumansCells
    94. Huo L, Wu L, Zhang MY, Hou YH, Ding XP, Fang JS. [Electrocorticography monitoring in microsurgical treatment of solitary cavernous angiomas]. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2008 May; 33(5):448-51. PMID: 18544851.
      Citations: 1     Fields:    Translation:Humans
    95. Huo L, Sneige N, Hunt KK, Albarracin CT, Lopez A, Resetkova E. Predictors of invasion in patients with core-needle biopsy-diagnosed ductal carcinoma in situ and recommendations for a selective approach to sentinel lymph node biopsy in ductal carcinoma in situ. Cancer. 2006 Oct 15; 107(8):1760-8. PMID: 16977650.
      Citations: 21     Fields:    Translation:Humans
    96. Huo L, Moran CA, Fuller GN, Gladish G, Suster S. Pulmonary artery sarcoma: a clinicopathologic and immunohistochemical study of 12 cases. Am J Clin Pathol. 2006 Mar; 125(3):419-24. PMID: 16613346.
      Citations: 25     Fields:    Translation:Humans
    97. Huo L, Lai S, Gladish G, Czerniak BA, Moran CA. Pulmonary artery angiosarcoma: a clinicopathologic and radiological correlation. Ann Diagn Pathol. 2005 Aug; 9(4):209-14. PMID: 16084454.
      Citations: 10     Fields:    Translation:Humans
    98. Huo L, Sugimura J, Tretiakova MS, Patton KT, Gupta R, Popov B, Laskin WB, Yeldandi A, Teh BT, Yang XJ. C-kit expression in renal oncocytomas and chromophobe renal cell carcinomas. Hum Pathol. 2005 Mar; 36(3):262-8. PMID: 15791570.
      Citations: 12     Fields:    Translation:Humans
    99. Gong Y, Sun X, Huo L, Wiley EL, Rao MS. Expression of cell adhesion molecules, CD44s and E-cadherin, and microvessel density in invasive micropapillary carcinoma of the breast. Histopathology. 2005 Jan; 46(1):24-30. PMID: 15656882.
      Citations: 13     Fields:    Translation:Humans
    100. Patton KT, Tretiakova MS, Yao JL, Papavero V, Huo L, Adley BP, Wu G, Huang J, Pins MR, Teh BT, Yang XJ. Expression of RON Proto-oncogene in Renal Oncocytoma and Chromophobe Renal Cell Carcinoma. Am J Surg Pathol. 2004 Aug; 28(8):1045-50. PMID: 15252311.
      Citations: 9     Fields:    Translation:HumansCells
    101. Chen LH, Liu YS, Yuan XR, Fang JS, Ma JR, Xi J, Yang ZQ, Huo L. [Microsurgical treatment for craniopharyngioma combined transorbital-subfrontal and temporal craniotomy]. Zhonghua Wai Ke Za Zhi. 2003 Apr; 41(4):282-5. PMID: 12882673.
      Citations: 1     Fields:    Translation:Humans
    102. Chen LH, Liu YS, Yuan XR, Fang JS, Ma JR, Xi J, Yang ZQ, Huo L. [Keyhole microsurgery for acoustic neurinomas through suboccipital retrosigmoid sinus approach]. Ai Zheng. 2002 Oct; 21(10):1136-40. PMID: 12508661.
      Citations: 1     Fields:    Translation:Humans
    103. Huo L, Scarpulla RC. Mitochondrial DNA instability and peri-implantation lethality associated with targeted disruption of nuclear respiratory factor 1 in mice. Mol Cell Biol. 2001 Jan; 21(2):644-54. PMID: 11134350.
      Citations: 74     Fields:    Translation:AnimalsCells
    104. Huo L, Scarpulla RC. Multiple 5'-untranslated exons in the nuclear respiratory factor 1 gene span 47 kb and contribute to transcript heterogeneity and translational efficiency. Gene. 1999 Jun 11; 233(1-2):213-24. PMID: 10375638.
      Citations: 5     Fields:    Translation:HumansAnimalsCells
    105. miR-141-mediated regulation of brain metastasis from breast cancer. Journal of the National Cancer Institute. 108.
    106. Impact of androgen receptor expression in fluoxymesterone-treated estrogen receptor-positive metastatic breast cancer refractory to contemporary hormonal therapy. Breast Cancer Research and Treatment. 160:101-109.
    107. Sodium/glucose co-transporter 1 expression increases in human diseased prostate. Journal of Cancer Science and Therapy. 4:306-312.
    108. The 21-gene recurrence score complements IBTR! Estimates in early-stage, hormone receptor-positive, HER2-normal, lymph node-negative breast cancer. SpringerPlus. 4.
    109. MicroRNA expression profiling identifies decreased expression of miR-205 in inflammatory breast cancer. Modern Pathology.
    110. Immunological and molecular studies in breast tumors. 209-243.
    111. Aberrant high expression of immunoglobulin G in epithelial stem/progenitor-like cells contributes to tumor initiation and metastasis. Oncotarget. 6:40081-40094.
    112. Triple-negative breast cancer has worse overall survival and cause-specific survival than non-triple-negative breast cancer. Breast Cancer Research and Treatment. 161:279-287.
    113. MiR-33a Decreases High-Density Lipoprotein-Induced Radiation Sensitivity in Breast Cancer. International Journal of Radiation Oncology Biology Physics.
    114. GATA-binding protein 3 enhances the utility of gross cystic disease fluid protein-15 and mammaglobin A in triple-negative breast cancer by immunohistochemistry. Histopathology.
    115. Nomograms for Predicting Axillary Response to Neoadjuvant Chemotherapy in Clinically Node-Positive Patients with Breast Cancer. Annals of Surgical Oncology. 1-9.
    116. Incremental cancer detection using breast ultrasonography versus breast magnetic resonance imaging in the evaluation of newly diagnosed breast cancer patients. British Journal of Radiology. 89.
    HUO's Networks
    Click the
    buttons for more information and interactive visualizations!
    Concepts (437)
    Co-Authors (104)
    Similar People (60)
    Same Department Expand Description